Bentham Science Logo

Contents

Current Cancer Drug Targets, Volume 14 - Number 6


Deubiquitinating Enzyme Inhibitors and their Potential in Cancer Therapy

, 14(6): 506 - 516

Bernat Crosas


DOI: 10.2174/1568009614666140725090620



Overview of Proteasome Inhibitor-Based Anti-cancer Therapies: Perspective on Bortezomib and Second Generation Proteasome Inhibitors versus Future Generation Inhibitors of Ubiquitin-Proteasome System

, 14(6): 517 - 536

Q. Ping Dou and Jeffrey A. Zonder


DOI: 10.2174/1568009614666140804154511



The Immunoproteasome as a Therapeutic Target for Hematological Malignancies

, 14(6): 537 - 548

Zachary Miller, Wooin Lee and Kyung Bo Kim


DOI: 10.2174/1568009614666140723113139



NEDD4: A Promising Target for Cancer Therapy

, 14(6): 549 - 556

Xiantao Ye, Lixia Wang, Bingxue Shang, Zhiwei Wang and Wenyi Wei


DOI: 10.2174/1568009614666140725092430



Arsenic Trioxide Exerts Anti-lung Cancer Activity by Inhibiting Angiogenesis

, 14(6): 557 - 566

Meng-Hang Yang, Yuan-Sheng Zang, Hai Huang, Kun Chen, Bing Li, Guang-Yuan Sun and Xue-Wei Zhao


DOI: 10.2174/1568009614666140725090000



Structure, Function, and Pathogenesis of SHP2 in Developmental Disorders and Tumorigenesis

, 14(6): 567 - 588

Wen-Qing Huang, Qing Lin, Xuan Zhuang, Liang-Liang Cai, Run-Sheng Ruan, Zhong-Xian Lu and Chi-Meng Tzeng


DOI: 10.2174/1568009614666140717105001





Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science